We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.105 | 2.26% | 4.755 | 4.52 | 4.99 | - | 189,060 | 16:35:30 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.53 | 9.36M |
| Date | Subject | Author | Discuss |
|---|---|---|---|
| 12/8/2020 13:18 | CV19 can also cause long term damage to vital organs & clotting of the blood. It really isn't all about the death rate. | eggy toast | |
| 12/8/2020 12:55 | @nobby could i be added to the other board please. Thanks. | mrrarmark82 | |
| 12/8/2020 11:56 | This is from .gov.! Surely anyone reading what the government have just updated us on in relation to deaths involving COVID and the all death rate can see this is not cherry picking. The June figures will likely increase but may still remain below the 5 year average death rate per 100,000 | westi1 | |
| 12/8/2020 11:30 | Vaccine for what ? Latest gov figures show no one under 65 has died from COVID in June 2020 As the majority of people who work are under 65 then surely no one under this age needs a Vaccine. No deaths at all below 65 and the vast majority are 90+. Even the headline figures at the beginning only relate to C-19 being an underlying cause of death. | westi1 | |
| 12/8/2020 11:29 | Haha. No I'm just being greedy. But I've seen mms play games like this for the past month. | bowssbyjuhelm | |
| 12/8/2020 11:27 | Is that 14.10 on the 24hr clock? | jjmills56 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
